Bengaluru: The UK's benchmark FTSE 100 index fell on Wednesday, dragged by healthcare shares after GSK warned of lower annual vaccine sales, while investors awaited the current government's first ...

and we knew we could put trust in Kuehne+Nagel's global experience in handling healthcare and consumer goods." Matthias Blan, Managing Director, Türkiye, Kuehne+Nagel adds: "We are excited to ...

GSK CEO Emma Walmsley's bet on blockbuster RSV vaccine, Arexvy, has hit a snag in recent months after the U.S. public health agency narrowed the age recommendation for use of RSV vaccines and ...

French pharma giant Sanofi is selling off its consumer healthcare business Opella ... focused and pursuing strategies based on innovative prescription drug portfolios. GSK, Johnson & Johnson, Pfizer, ...

A bill that would allow state government to shift money between health benefit funds sailed from introduction to the governor’s desk in just a week, as New Jersey again faces a potential ...

After leading the New Jersey Division of Consumer Affairs on an interim basis ... as a deputy general counsel to the U.S. Department of Health and Human Services. As head of the DCA, Fais ...

Sen. Elizabeth Warren (D-Mass.) is urging the Federal Trade Commission to scrutinize recent deals from McKesson and Cardinal Health to buy oncology practices, saying those transactions pose ...

US pharma major GSK (LSE: GSK) yesterday announced new preliminary data for Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted) in adults aged 18-49 at increased risk for RSV-LRTD due ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.